Skip to content
Sign In Get a Demo

Condition focused protocols to support clinical decision making

Creyos offers evidence-based cognitive assessments to help providers identify and monitor symptoms tied to conditions like ADHD and MCI—enabling earlier action and better outcomes.

 

Get a Demo

Hero-3
Scientifically Superior

Backed by data

Developed by neuroscientists, protocols are supported by 30 years of research and a robust normative database, making them it a scientifically superior options for objective condition testing. 

Sensitivity

Domain specific

Creyos batteries assess the distinct cognitive domains impacted by conditions like dementia and ADHD, offering detailed, clinically relevant insights that go beyond general screening tools

Result Interpretation

Easy to interpret 

Protocols generate concise reports displaying patient performance on cognitive assessments and how it compares to healthy norms, enabling quick identification of cognitive issues.

Formulated from decades of scientific research 

Condition-focused protocols have been carefully designed based on extensive scientific review and validation. The cognitive tests and questionnaires that comprise each protocol are all proven to align with markers and brain function of the conditions being tested. They leverage hundreds of proprietary and condition-specific research studies to ensure maximum specificity and sensitivity. 

Protocol - Scientific Research

Administrative efficiency meets a quality patient experience

Condition-focused protocols are designed for effortless administration by healthcare professionals and ease of completion for patients. Pre-selected tasks and questionnaires streamline setup, while embedded instructions ensure a seamless patient experience, setting expectations for each step and clearly guiding them through the requirements.

Efficacy

Rapid dementia screening, assessment, and care

Creyos offers providers an end-to-end solution for cognitive screening, assessment, and care, helping to save practices time while delivering a better patient experience. 

Detect

Assess

Care

Track

Detect-3

Cognitive screening tools to detect even mild impairment

Creyos enables quick screening for measuring cognitive impairment in a patient-friendly two-task assessment. The test takes under 5-minutes to complete and is as easy to administer as the Montreal cognitive assessment (MoCA test) but sensitive enough to detect even mild cognitive impairment (MCI). With a clear report, it informs healthcare providers the degree of cognitive impairment and whether further cognitive testing is required.

We've seen that patients are more invested in their health and they pay more attention to the deficits that showed up in testing. During follow up appointments, they let us know if things have gotten better or worse. We can re-test them using quantitative measures and show them the side-by-side comparison to their earlier results

Melissa Picchione

Medical Director

Yukon Neurology

Reliably identify cognitive markers of attention deficits and hyperactivity

A scientifically-validated protocol that tests cognitive domains linked to ADHD, the Creyos assessment takes minutes to complete and provides clinicians with clarity and accuracy around the presence or absence of potential ADHD markers. 


Get a Demo

Objective Online Assessment

Age-Appropriate Questionnaires

One Easy-to-Interpret Report

Protocol - Online Assessment

Objective testing for ADHD markers

The Creyos ADHD protocol includes a battery of cognitive tests to measure attention and executive function, including a sustained attention to response task (the SART) that measures continuous performance. Performance on these tasks is measured against the typical range for 14 specific ADHD markers, to show whether a patient falls in or out of norms. 

Creyos supports my decision-making. Having these reports gives me clear answers about where there are deficits, like in attention, versus other types of measures. I’m really able to read out a patient’s specific symptoms and target which medication I think will work best for them

Gabrielle Thompson

Founder and FNP-C

GT Healthcare

Looking to streamline cognitive testing, without sacrificing precision?

Connect with us to learn how our protocols can elevate your practice.

Get a Demo